Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

Published:2004-10 Issue:9444 Volume:364 Page:1489-1496
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Filippi Massimo,Rovaris Marco,Inglese Matilde,Barkhof Frederik,De Stefano Nicola,Smith Steve,Comi Giancarlo

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis;Rovaris;Curr Opin Neurol,1999

2. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis;Filippi;Neurology,1994

3. The prognostic value of brain MRI in clinically isolated syndromes of the CNS: a 10-year follow-up;O'Riordan;Brain,1998

4. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis;Brex;N Engl J Med,2002

5. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance;Miller;Brain,2002

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted DeSUMOylation as a therapeutic strategy for multiple sclerosis;Journal of Neuroimmunology;2024-07

2. Immunoinformatics for the Diagnosis and Monitoring of Autoimmune Diseases;Interdisciplinary Biotechnological Advances;2024

3. Introduction to multiple sclerosis;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

4. A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain Atrophy;Annals of Neurology;2023-10-18

5. Disease‐modifying therapies in multiple sclerosis: A focused review of rituximab;Basic & Clinical Pharmacology & Toxicology;2023-09-20